Metabolic dysfunction-associated steatotic liver disease and gastroesophageal reflux disease: a mendelian randomization study in European and East Asian populations

被引:0
|
作者
Su, Chen'guang [1 ]
Liao, Zheng [1 ]
Li, Hewen [2 ]
Pei, Yinxuan [1 ]
Wang, Zixiang [1 ]
Li, Jian [1 ]
Liu, Jinlong [1 ,3 ]
机构
[1] Chengde Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp, Chengde, Hebei, Peoples R China
[2] Chengde Med Univ, Dept Minimally Invas Spine Surg, Affiliated Hosp, Chengde, Hebei, Peoples R China
[3] Hebei Key Lab Panvasc Dis, Chengde, Hebei, Peoples R China
关键词
metabolic dysfunction-associated steatotic liver disease; gastroesophageal reflux disease; mendelian randomization; causal effect; genome-wide association studies; ALANINE AMINOTRANSFERASE; RISK-FACTORS; ESOPHAGITIS; PREVALENCE; OBESITY; INSTRUMENTS; SYMPTOMS; BIAS;
D O I
10.3389/fgene.2024.1428334
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Numerous observational studies have shown a potential association between metabolic dysfunction-associated steatotic liver disease (MASLD) and gastroesophageal reflux disease (GERD). However, causality is unclear. This study utilized genome-wide association study (GWAS) genetic data to explore the causal relationship between MASLD and GERD in European and East Asian populations. Methods This study utilized a bidirectional, two-sample Mendelian randomization (MR) approach. All disease data were obtained from the GWAS database, and single nucleotide polymorphisms strongly associated with exposure were selected as instrumental variables. The inverse variance weighted (IVW) method is primarily utilized to evaluate the causal relationship between exposure and outcome. Finally, sensitivity analyses were performed to ensure the robustness of the results. Results The IVW estimates indicated that non-alcoholic fatty liver disease (NAFLD) (odds ratio (OR) = 1.054, 95% confidence interval (CI), 0.966-1.150, p = 0.236) and percent liver fat (OR = 0.977, 95% CI, 0.937-1.018, p = 0.258) in European population were not linked to a higher risk of GERD. However, GERD in European population was associated with an increased risk of NAFLD (OR = 1.485, 95% CI, 1.274-1.729, p < 0.001) and percent liver fat (OR = 1.244, 95% CI, 1.171-1.321, p < 0.001). In addition, the IVW analysis in East Asian population showed that alanine aminotransferase (ALT) was associated with an increased risk of GERD (OR = 2.305, 95% CI, 1.241-4.281, p = 0.008), whereas aspartate aminotransferase (AST) had no causal effects on GERD risk (OR = 0.973, 95% CI, 0.541-1.749, p = 0.926). Furthermore, the associations between GERD and ALT (OR = 1.007, 95% CI, 0.998-1.015, p = 0.123) or AST (OR = 1.004, 95% CI, 0.997-1.012, p = 0.246) were not significant. After removing outliers, a significant correlation between GERD and ALT was observed (OR = 1.009, 95% CI, 1.001-1.016, p = 0.020). Conclusion There was reverse causality between MASLD and GERD in European population, while there was bidirectional causality between a proxie for MASLD (ALT) and GERD in East Asian population. This study can provide novel insights into cross-ethnic genetic research on MASLD and GERD.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
    Paklar, Natasa
    Mijic, Maja
    Filipec-Kanizaj, Tajana
    BIOMEDICINES, 2023, 11 (11)
  • [32] Mendelian randomization study of gastroesophageal reflux disease and major depression
    Zheng, Xiaofei
    Zhou, Xin
    Tong, Li
    Gu, Wang
    Wang, Siyu
    Yuang, Wenkang
    Zhang, Chong
    Zhang, Chaoyang
    Zhang, Chao
    Wan, Bangbei
    PLOS ONE, 2023, 18 (09):
  • [33] Association between metabolic dysfunction-associated steatotic liver disease and pulmonary function: a population-based and two-sample mendelian randomization study
    Feng, Ting
    Li, Jiaming
    Wu, Lihao
    He, Xingxiang
    Ye, Junzhao
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [34] Serum folate levels and risk of metabolic dysfunction-associated steatotic liver disease: results from a cross-sectional study and Mendelian randomization analysis
    Chen, Yalan
    Gao, Jie
    Wang, Xibin
    Lu, Hong
    Zheng, Ya
    Ren, Qian
    FRONTIERS IN NUTRITION, 2024, 11
  • [35] Metabolic dysfunction-associated steatotic liver disease increases cardiovascular disease risk in young adults
    Chung, Goh Eun
    Yu, Su Jong
    Yoo, Jeong-Ju
    Cho, Yuri
    Lee, Kyu-na
    Shin, Dong Wook
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Han, Kyungdo
    Cho, Eun Ju
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [36] Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease
    Gulati, Reeti
    Moylan, Cynthia A.
    Wilder, Julius
    Wegermann, Kara
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (02):
  • [37] Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease
    Wakabayashi, Shun-Ichi
    Tamaki, Nobuharu
    Kimura, Takefumi
    Umemura, Takeji
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (06) : 494 - 503
  • [38] Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology
    Portincasa, Piero
    Baffy, Gyorgy
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 35 - 39
  • [39] Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Beyoglu, Diren
    Popov, Yury V.
    Idle, Jeffrey R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [40] Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
    Platek, Anna E.
    Szymanska, Anna
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 187 - 192